title: Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects.
abstract: OBJECTIVE
  Subclinical hypercortisolism (SH) has been associated with increased prevalence of hypertension, type 2 diabetes mellitus, dyslipidaemia, central obesity, osteoporosis and vertebral fractures. We aimed to investigate the accuracy of different SH diagnostic criteria in predicting the presence of complications.
  
  
  METHODS
  This was a retrospective study.
  
  
  METHODS
  We evaluated data from 231 patients (120 women and 111 men) affected with adrenal incidentalomas (AI).
  
  
  METHODS
  We studied the accuracy of different SH diagnostic criteria (cortisol after 1 mg overnight dexamethasone suppression test - 1mg-DST - at different cut-off such as 49.7, 82.8, 137.9 nmol/l, elevated urinary free cortisol, reduced adrenal corticotroph hormone (ACTH) levels alone or various combination of these parameters) in predicting the concomitant presence of the following three complications: hypertension, type 2 diabetes and vertebral fractures.
  
  
  RESULTS
  The criterion characterized by the presence of two of 1mg-DST >82.8 nmol/l, elevated UFC and reduced ACTH struck the best balance between sensitivity and specificity, reaching a good accuracy in predicting the cluster of complications (61.9%; 77.1% and 75.8%, respectively). The presence of this cluster was associated with this criterion (OR 4.75, 95%CI 1.8-12.7, P = 0.002) regardless of gonadal status, body mass index (BMI) and age.
  
  
  CONCLUSIONS
  The SH criterion characterized by the presence of two of 1mg-DST >82.8 nmol/l, elevated UFC and reduced ACTH seems the best in predicting the presence of chronic manifestations of subtle cortisol excess.
authors.affiliation: Unit of Endocrinology and Diabetology, Department of Medical Sciences, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan.
authors.forename: V
authors.initials: V
authors.lastname: Morelli
authors.forename: B
authors.initials: B
authors.lastname: Masserini
authors.forename: A S
authors.initials: AS
authors.lastname: Salcuni
authors.forename: C
authors.initials: C
authors.lastname: Eller-Vainicher
authors.forename: C
authors.initials: C
authors.lastname: Savoca
authors.forename: R
authors.initials: R
authors.lastname: Viti
authors.forename: F
authors.initials: F
authors.lastname: Coletti
authors.forename: G
authors.initials: G
authors.lastname: Guglielmi
authors.forename: C
authors.initials: C
authors.lastname: Battista
authors.forename: L
authors.initials: L
authors.lastname: Iorio
authors.forename: P
authors.initials: P
authors.lastname: Beck-Peccoz
authors.forename: B
authors.initials: B
authors.lastname: Ambrosi
authors.forename: M
authors.initials: M
authors.lastname: Arosio
authors.forename: A
authors.initials: A
authors.lastname: Scillitani
authors.forename: I
authors.initials: I
authors.lastname: Chiodini
mesh_terms: D000236:Adenoma / Q000150:complications / Q000175:diagnosis; D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000175:diagnosis; D000324:Adrenocorticotropic Hormone / Q000032:analysis / Q000097:blood; D000368:Aged; D003480:Cushing Syndrome / Q000150:complications / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D003907:Dexamethasone; D005260:Female; D006801:Humans; D006854:Hydrocortisone; D033162:Incidental Findings; D008297:Male; D008875:Middle Aged; D010912:Pituitary-Adrenal Function Tests; D011237:Predictive Value of Tests; D012189:Retrospective Studies
chemical_list: D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone